IBBvsJDOC
iShares Biotechnology ETF against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | JDOC | |
|---|---|---|
| Expense ratio | 0.45% | 0.65% |
| Assets | $10.9B | $8911.98T |
| Net flow, 1 month | +$272M | — |
| Net flow, 1 year | +$1.8B | −$25K |
| Return, YTD | +21.6% | +2.9% |
| Return, 1 year | +36.0% | +9.4% |
| Avg daily volume | 1.5M | 229 |
| Holdings | 221 | 67 |
| Listed | Feb 5, 2001 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS